Advisor Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Advisor Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4K	Hold	1,013	–	–	﹤0.01%	4794
2019 Q3	$8K	Buy	1,013 +1,000	+7,692%	+$8.09K	﹤0.01%	4472
2019 Q2	$0	Hold	13	–	–	﹤0.01%	5413
2019 Q1	$0	Sell	13 -410	-97%	-$4.39K	﹤0.01%	5371
2018 Q4	$4K	Sell	423 -15	-3%	-$191	﹤0.01%	4651
2018 Q3	$7K	Buy	+438	New	+$9.48K	﹤0.01%	4471
2018 Q2	–	Sell	-108	Closed	-$2K	–	5085
2018 Q1	$2K	Hold	108	–	–	﹤0.01%	4729
2017 Q4	$2K	Hold	108	–	–	﹤0.01%	4730
2017 Q3	$2K	Buy	+108	New	+$977	﹤0.01%	4593
2017 Q1	–	Sell	-235	Closed	-$1K	–	4835
2016 Q4	$1K	Hold	235	–	–	﹤0.01%	4422
2016 Q3	$1K	Hold	235	–	–	﹤0.01%	4380
2016 Q2	$1K	Buy	+235	New	+$1.66K	﹤0.01%	4294

Other funds holding SPPI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Advisor Group's SPPI Position: Q4 2019 in Review

Advisor Group held its Spectrum Pharmaceuticals Inc (SPPI) position steady in Q4 2019 at 1,013 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4794.

Advisor Group first reported a position in SPPI in Q2 2016 and has held it in 12 quarters since. The position peaked at $8K in Q3 2019. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

Advisor Group held 1,013 shares of Spectrum Pharmaceuticals Inc worth $4K as of Q4 2019.
Advisor Group left its Spectrum Pharmaceuticals Inc share count unchanged in Q4 2019.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4794 holding.
Advisor Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and has held it in 12 quarters since.
Advisor Group's Spectrum Pharmaceuticals Inc position peaked at $8K in Q3 2019.
169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.